-$910.4M
Net Activity
Institutions Holding
261
Popularity Rank
#2280
Avg Weight
0.17%
Total Value
$3.1B
261 institutions currently hold TVTX, with 134 net buyers and 155 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
155
Net Buying Institutions
134
Top 5 by Value
+$1.9B
Total Buy Value
$2.0B
Total Sell Value
134
Net Buyers
155
Net Sellers
2
Filings (90d)
$725K
Total Est. Value
15K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Baynes Roy D. | 2026-06-12 | $225K |
| Coughlin Timothy | 2026-06-12 | $500K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Sandra Calvin, Chief Accounting Officer of Travere Therapeutics, notified the company she plans to retire in February 2027 after the annual report is filed. Vice President and Controller John Torell is expected to succeed her as CAO, and the board will appoint him before her departure to ensure a smooth transition.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter